Chikungunya fever
Conditions
Interventions
58 patients were recruited and subjects were randomized into two groups of 29 patients each (active group and sham group).
A total of 06 sessions lasting 20 minutes each were administered to participa
Other
E02.331.750
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Age
No minimum to 70 Years
Inclusion criteria
Inclusion criteria: Man or woman aged 18 or older; be in chronic phase of chikungunya fever (least 3 month of the initial infection) and show laboratory tests or clinical diagnostic confirmation of chikungunya virus; pain related with more than 4 in a numeric rating scale; to have physical capacity to do physical evaluation and be capable of consenting to treatment and understanding study explanations and questionnaires; having provided informed consent
Exclusion criteria
Exclusion criteria: Electrical implants in the body; a history of epilepsy; people who are clinically contraindicated to receive tDCS such as having metal embedded in their scalp or brain; psychiatric illness, and history of drug abuse; pregnant women; signs of severity and/or indication of hospitalization; presence of previous rheumatic disease including gout, rheumatoid arthritis, fibromyalgia, lupus and others chronic pain syndromes with diagnosis prior to chikungunya
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain improvement in patients in the active group who received a 6-day treatment with tDCS by assessing the visual analog pain scale with a predicted improvement of 3 points for clinically perceptible outcomes | — |
Secondary
| Measure | Time frame |
|---|---|
| Functionality improvement in patients in the active group who received 10-day treatment with tDCS assessing the HAQ functionality scale with a significant increase in their scor | — |
Countries
Brazil
Contacts
Public ContactRodrigo Freitas
Universidade federal do rio grande do norte
Outcome results
None listed